~~<i id='346CE0A501'><strike id='346CE0A501'><tt id='346CE0A501'><pre id='346CE0A501'></pre></tt></strike></i>~~

Home» focus» Wikipedia

Wikipedia

author：entertainment 2025-09-27 20:17:31 Page View：36549

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Novo Nordisk touts Wegovy study, but still struggling with supply
Next article： The Supreme Court will review a ruling striking down a domestic violence federal gun ban

explore

Heart attack and stroke risk calculators need revising

AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

Ionis has late

AdobeIonisPharmaceuticals,aCaliforniabiotechthathasspearheadedthedevelopmentofRNA-targetingmedicines

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

WASHINGTON--TheSupremeCourtwillreviewarulingstrikingdownadomesticviolencefederalgunban.

Bird flu researchers hone in on Finland’s mink farms

MinkslookoutfromacageatafurfarminBelarus.SergeiGrits/APHELSINKI—ItwasthequietthatstoodouttoTarjaSiro